3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
560
Carcinoma, Non-Small-Cell Lung
517
Prostatic Neoplasms
336
Colorectal Neoplasms
273
Neoplasms
269
Multiple Myeloma
267
Leukemia, Myeloid, Acute
225
Squamous Cell Carcinoma of Head and Neck
217
Lung Neoplasms
211
Neoplasm Metastasis
205
Carcinoma, Hepatocellular
198
Melanoma
175
Triple Negative Breast Neoplasms
174
Pancreatic Neoplasms
172
Recurrence
153
Ovarian Neoplasms
152
Lymphoma
142
Glioblastoma
136
Brain Neoplasms
134
Sarcoma
131
Carcinoma, Renal Cell
129
Lymphoma, Large B-Cell, Diffuse
126
Leukemia, Lymphocytic, Chronic, B-Cell
126
Stomach Neoplasms
125
Head and Neck Neoplasms
125
Precursor Cell Lymphoblastic Leukemia-Lymphoma
110
Rectal Neoplasms
109
Myelodysplastic Syndromes
104
Uterine Cervical Neoplasms
100
Urinary Bladder Neoplasms
100
Interventions
Interleukin 1 Receptor Antagonist Protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Early Stage Triple Negative ER Low Breast Cancer
×
1 year
×
Clear all
NCT06710197
2026-03-05
OZM-034
University Health Network, Toronto
Phase 2
Withdrawn